These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 15526347

  • 61. Activated MR contrast agents.
    Lowe MP.
    Curr Pharm Biotechnol; 2004 Dec; 5(6):519-28. PubMed ID: 15579041
    [Abstract] [Full Text] [Related]

  • 62. Elucidating structure-function relationships from molecule-to-cell-to-tissue: from research modalities to clinical realities.
    Dobrucki LW, Marsh BJ, Kalinowski L.
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():83-93. PubMed ID: 20083856
    [Abstract] [Full Text] [Related]

  • 63. Toward the engineering of minimal living cells.
    Luisi PL.
    Anat Rec; 2002 Nov 01; 268(3):208-14. PubMed ID: 12382319
    [Abstract] [Full Text] [Related]

  • 64. (19)F MRI monitoring of gene expression in living cells through cell-surface β-lactamase activity.
    Matsushita H, Mizukami S, Mori Y, Sugihara F, Shirakawa M, Yoshioka Y, Kikuchi K.
    Chembiochem; 2012 Jul 23; 13(11):1579-83. PubMed ID: 22777922
    [Abstract] [Full Text] [Related]

  • 65. Cell labeling for magnetic resonance imaging with the T1 agent manganese chloride.
    Aoki I, Takahashi Y, Chuang KH, Silva AC, Igarashi T, Tanaka C, Childs RW, Koretsky AP.
    NMR Biomed; 2006 Feb 23; 19(1):50-9. PubMed ID: 16411253
    [Abstract] [Full Text] [Related]

  • 66. Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.
    Slotkin JR, Cahill KS, Tharin SA, Shapiro EM.
    Neurotherapeutics; 2007 Jul 23; 4(3):428-33. PubMed ID: 17599708
    [Abstract] [Full Text] [Related]

  • 67. Design and characterization of magnetic resonance imaging gene reporters.
    Louie A.
    Methods Mol Med; 2006 Jul 23; 124():401-17. PubMed ID: 16506432
    [Abstract] [Full Text] [Related]

  • 68. Role of Contrast in MR Imaging.
    Chandra T, Mohan S.
    Top Magn Reson Imaging; 2016 Aug 23; 25(4):151-6. PubMed ID: 27367311
    [Abstract] [Full Text] [Related]

  • 69. Perspective: time scales in scientific research with an emphasis on microbial cellular and molecular research.
    Trevors JT.
    J Microbiol Methods; 2010 Jul 23; 82(1):102-7. PubMed ID: 20350572
    [Abstract] [Full Text] [Related]

  • 70. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system.
    Riegler J, Wells JA, Kyrtatos PG, Price AN, Pankhurst QA, Lythgoe MF.
    Biomaterials; 2010 Jul 23; 31(20):5366-71. PubMed ID: 20382425
    [Abstract] [Full Text] [Related]

  • 71. Analytical biotechnology: from single molecule and single cell analyses to population dynamics of metabolites and cells.
    Schmid A, Neubauer P.
    Curr Opin Biotechnol; 2010 Feb 23; 21(1):1-3. PubMed ID: 20189376
    [No Abstract] [Full Text] [Related]

  • 72. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
    Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN.
    Chem Rev; 2008 Jun 23; 108(6):2064-110. PubMed ID: 18543879
    [No Abstract] [Full Text] [Related]

  • 73. Recent advances in iron oxide nanocrystal technology for medical imaging.
    Corot C, Robert P, Idée JM, Port M.
    Adv Drug Deliv Rev; 2006 Dec 01; 58(14):1471-504. PubMed ID: 17116343
    [Abstract] [Full Text] [Related]

  • 74. Gold nanoparticles: a new X-ray contrast agent.
    Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM.
    Br J Radiol; 2006 Mar 01; 79(939):248-53. PubMed ID: 16498039
    [Abstract] [Full Text] [Related]

  • 75. Cellular MR imaging.
    Modo M, Hoehn M, Bulte JW.
    Mol Imaging; 2005 Mar 01; 4(3):143-64. PubMed ID: 16194447
    [Abstract] [Full Text] [Related]

  • 76. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
    Gupta AK, Gupta M.
    Biomaterials; 2005 Jun 01; 26(18):3995-4021. PubMed ID: 15626447
    [Abstract] [Full Text] [Related]

  • 77. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
    Shevtsov MA, Nikolaev BP, Yakovleva LY, Marchenko YY, Dobrodumov AV, Mikhrina AL, Martynova MG, Bystrova OA, Yakovenko IV, Ischenko AM.
    Int J Nanomedicine; 2014 Jun 01; 9():273-87. PubMed ID: 24421639
    [Abstract] [Full Text] [Related]

  • 78. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use with MRI and other biomedical applications.
    Yoffe S, Leshuk T, Everett P, Gu F.
    Curr Pharm Des; 2013 Jun 01; 19(3):493-509. PubMed ID: 22934920
    [Abstract] [Full Text] [Related]

  • 79. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
    Wahajuddin, Arora S.
    Int J Nanomedicine; 2012 Jun 01; 7():3445-71. PubMed ID: 22848170
    [Abstract] [Full Text] [Related]

  • 80. Magnetic iron oxide nanoparticles for biomedical applications.
    Laurent S, Bridot JL, Elst LV, Muller RN.
    Future Med Chem; 2010 Mar 01; 2(3):427-49. PubMed ID: 21426176
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.